• Applied Biosystems (Foster City, California), an Applera business, said that researchers now have a new tool to enable the discovery of microRNAs and other small RNA molecules using the latest genomic analysis technology. The company said it has enhanced its solution for performing sensitive digital gene expression analysis on its next-generation sequencing platform with its new SOLiD RNA expression solution. The offering includes a new sample preparation kit to enable high-throughput discovery of novel RNA molecules without requiring previous knowledge of sequence information. The kit converts total RNA into a library suitable for input into the SOLiD system workflow for high-throughput genomic analysis. Applied said that the kit is expected to improve the detection of biologically relevant changes for researchers working with small RNA molecules.

• Encision (Boulder, Colorado) said that it is launching its new disposable hand-activated fixed-tip electrode line of laparoscopic instruments. The new electrode line features hand activation for surgeons who prefer to energize the electrode via a fingertip switch rather than pressing their foot on a foot pedal. The new product line consists of a disposable handle with integral cord and disposable electrodes available in six popular tip styles. The disposable electrodes are available in both 35cm lengths for routine procedures and 45cm lengths for bariatric procedures. Encision makes surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures.

• Home Guardian (Charlottesville, Virginia) reported the release of a suite of sensors that non-intrusively monitor the health status of seniors in their homes while enabling professional caregivers to provide needed care. This includes the detection of falls, which constitute the largest cause of injuries for people over age 65 in the U.S. Immediate benefits of the sensor systems include: a reduction of the cost of care of nearly 75%; increased feelings of safety and security in participants; less job-related stress for caregivers. Home Guardian's services provide family and professional caregivers with access to the current health status of their charges through discreet technology.

• Third Wave Technologies (Madison, Wisconsin) reported FDA clearance of its InPlex CF molecular test which simultaneously detects and identifies cystic fibrosis mutations in patient DNA samples. The company said that the InPlex delivers the accuracy of Third Wave's Invader chemistry in a microfluidic card developed in collaboration with 3M (St. Paul, Minnesota). The InPlex is a genotyping test that provides information for cystic fibrosis carrier screening for adults of reproductive age as an aid in newborn screening for cystic fibrosis, and in confirmatory diagnostic testing for cystic fibrosis in newborns and children.